These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 4480270
1. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease]. Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H. Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1853-64. PubMed ID: 4480270 [No Abstract] [Full Text] [Related]
2. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 2. The importance of anamnestic and diagnostic characteristics for successful therapy]. Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H. Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1864-72. PubMed ID: 4615714 [No Abstract] [Full Text] [Related]
3. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 4. Results of a summarizing evaluation with factor analysis and multiple regression analysis]. Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H. Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1879-93. PubMed ID: 4155951 [No Abstract] [Full Text] [Related]
4. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy]. Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H. Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950 [No Abstract] [Full Text] [Related]
5. [Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients]. Lipnitskiĭ TN, Sheverda MG, Otkalenko IuK, Brovko AKh, Bogdanov EA. Vrach Delo; 1986 Aug; (8):5-8. PubMed ID: 3776159 [No Abstract] [Full Text] [Related]
9. [Tolerance and effectiveness of Cormelian in patients with coronary disease]. Messerich J. Med Welt; 1972 Apr 08; 23(15):563-6. PubMed ID: 5038526 [No Abstract] [Full Text] [Related]
11. [Clinical experiences with hexobendine in coronary disease]. Eral N. Arzneimittelforschung; 1968 Aug 08; 18(8):1094-103. PubMed ID: 5755844 [No Abstract] [Full Text] [Related]
12. [Polygraphic and electrocardiographic study of a new coronary therapeutic agent: dilazep]. Parenti B, Selvaggi R. Clin Ter; 1980 Jan 31; 92(2):155-63. PubMed ID: 7389275 [No Abstract] [Full Text] [Related]
13. [Status of the mnestic function of ischemic heart disease patients]. Khodzhaev AI, Alieva GE. Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Jan 31; 86(3):369-71. PubMed ID: 2871681 [Abstract] [Full Text] [Related]
16. [Treatment of therapy-resistant stenocardias associated with myocardial insufficiency using cormelian-digotab in a rehabilitation clinic]. Koeffler H. Fortschr Med; 1974 Dec 19; 92(35-36):1458-61. PubMed ID: 4435699 [No Abstract] [Full Text] [Related]
17. [Carbochromen in therapy of acute and chronic coronary insufficiency]. Votcal BE, Lozinskij LG. Arzneimittelforschung; 1970 Mar 19; 20():459-60. PubMed ID: 4989254 [No Abstract] [Full Text] [Related]
18. [Value of dilazep in the treatment of coronary insufficiency. A randomized and double-blind study on subjects with stable, exertion angina]. Romano M, De Caprio L, Scarafile P, Carlomagno A, Meccariello P, Condorelli M. Minerva Cardioangiol; 1980 Mar 19; 28(7-8):489-94. PubMed ID: 7005711 [No Abstract] [Full Text] [Related]